HCPCS Level II · Outpatient PPS (temporary codes)
C9142Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
Terminated 12/31/2022
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About C9142
C9142 is an HCPCS Level II code in the C series (outpatient PPS (temporary codes)), describing injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg.
It was added to HCPCS effective 10/01/2022, and its current record took effect 01/01/2023.
It was terminated on 12/31/2022 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Inj, alymsys, 10 mg
- Date added
- 10/01/2022
- Action effective
- 01/01/2023
- Termination date
- 12/31/2022
- BETOS
- O1E
Related C91xx codes
Common questions about C9142
Is HCPCS C9142 still valid?
- No. C9142 was terminated on 12/31/2022.
Does Medicare cover C9142?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.